Safety and efficacy of extended expectant management in preterm premature rupture of membrane between 32 and 34 weeks of pregnancy-A randomization control trial.

Ghosh D, Jena P, Sahu PS, Pradhan DD, Panda J, Panda B

Open source

DOI
10.1016/j.ejogrb.2025.113971
Published
2025 Jun
Container
European journal of obstetrics, gynecology, and reproductive biology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejogrb.2025.113971,
  title = {Safety and efficacy of extended expectant management in preterm premature rupture of membrane between 32 and 34 weeks of pregnancy-A randomization control trial.},
  author = {Ghosh D and Jena P and Sahu PS and Pradhan DD and Panda J and Panda B},
  year = {2025},
  journal = {European journal of obstetrics, gynecology, and reproductive biology},
  doi = {10.1016/j.ejogrb.2025.113971},
  url = {https://doi.org/10.1016/j.ejogrb.2025.113971}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of extended expectant management in preterm premature rupture of membrane between 32 and 34 weeks of pregnancy-A randomization control trial.
AU  - Ghosh D
AU  - Jena P
AU  - Sahu PS
AU  - Pradhan DD
AU  - Panda J
AU  - Panda B
PY  - 2025
JO  - European journal of obstetrics, gynecology, and reproductive biology
DO  - 10.1016/j.ejogrb.2025.113971
UR  - https://doi.org/10.1016/j.ejogrb.2025.113971
ER  - 

APA

D, G., P, J., PS, S., DD, P., J, P., & B, P. (2025). Safety and efficacy of extended expectant management in preterm premature rupture of membrane between 32 and 34 weeks of pregnancy-A randomization control trial.. European journal of obstetrics, gynecology, and reproductive biology. https://doi.org/10.1016/j.ejogrb.2025.113971

Source records